A contractor that makes ingredients for Johnson & Johnson’s COVID-19 vaccine said in an April 19 filing that federal regulators ordered a stoppage to its production of the drug substance for the duration of an inspection at a Maryland facility that was previously plagued with a contamination issue.
The company didn’t immediately return a request from The Epoch Times for information about how long the manufacturing pause could last and for comment on the stoppage, but Emergent told Politico in a statement that it’s working with both Johnson & Johnson and the FDA “on strengthening the supply chain for this vitally important vaccine.”
“We acknowledge that there are improvements we must make to meet the high standards we have set for ourselves and to restore confidence in our quality systems and manufacturing processes,” Emergent told the outlet.
Commenting on the manufacturing stoppage at Bayview, Johnson & Johnson told Reuters that, “at this time, it is premature to speculate on any potential impact this could have on the timing of our vaccine deliveries.”
Johnson & Johnson has previously said it would deliver 100 million doses of its vaccine to the United States during the first half of 2021, and so far it has delivered about 18 million doses.
“Specifically, the Company is adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the Company specialists already at Emergent,” Johnson & Johnson stated.
“The company will work with the U.S. Government to identify an alternative location for domestic drug substance production,” AstraZeneca stated.
The Bayview plant manufacturing pause is the latest setback to Johnson & Johnson’s efforts to increase production of its one-shot vaccine.
“By Friday, we should have an answer as to where we’re going with it. I would think that we’re not going to go beyond Friday in the extension of this pause,” said Fauci, who heads the National Institute of Allergy and Infectious Diseases.